Press Releases

Date Title and Summary View
Sep 04, 2003
HHS Names UTMB, Seven Others as New Regional Centers To Focus on Biodefense Research
HHS Names UTMB, Seven Others as New Regional Centers To Focus on Biodefense Research The Department of Health and Human Services (HHS) today announced that the University of Texas Medical Branch at Galveston (UTMB) is among eight institutions nationwide receiving grants totaling approximately $350
Additional Formats
Jun 07, 2002
MacroGenics Acquires Eliance, Inc., and Establishes Partnership in Immunotherapeutics with UT Southwestern.

$12.6 Million in Financing Completed

Additional Formats
Apr 01, 2002
MacroGenics Announces Senior Appointments
MacroGenics Announces Senior Appointments Rockville, MD April 1, 2002 - MacroGenics, Inc., a biotechnology company that is developing immunotherapeutics for treating cancer and inflammatory diseases, announced two key appointments to the senior management team. Michael S.
Additional Formats
Sep 25, 2001
MacroGenics Raises $13.5 Million and Appoints President and CEO

Former MedImmune Senior Vice President joins MacroGenics; Company completes key license agreements and closure of second tranche of Series A financing, bringing total raised to $13.5MM.

Additional Formats